Evidence map›Paper›PMID 26446859›Full record

ArticlePharmacoEconomics2016

National Database for Autism Research (NDAR): Big Data Opportunities for Health Services Research and Health Technology Assessment.

Nalin Payakachat, J Mick Tilford, Wendy J Ungar

Abstract read
In one paragraph

Article in PharmacoEconomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. AI and neuroimaging in autism spectrum disorder: advances in diagnosis, methodological challenges and future directions.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  4. Observational
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Big Data Technology Oriented to Wetland Resource Ecosystem Value Evaluation.Computational intelligence and neuroscience · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Nalin PayakachatDivision of Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Slot 522, Little Rock, AR, 72205, USA. npayakachat@uams.edu.
J Mick TilfordDivision of Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Slot 522, Little Rock, AR, 72205, USA.
Wendy J UngarChild Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada.
University of Arkansas for Medical Sciences · USInstitute for Clinical Evaluative Sciences · CA

Funding

Mapping Clinical Outcomes to Preference-based Measures from the NDAR DatabaseR03MH102495 · NIMH · UNIV OF ARKANSAS FOR MED SCIS · PI PAYAKACHAT, NALIN · 2014 to 2015
$149k
NIMH NIH HHS R03 MH102495NIMH NIH HHS R03MH102495
6 · The paper itself

Abstract

The National Database for Autism Research (NDAR) is a US National Institutes of Health (NIH)-funded research data repository created by integrating heterogeneous datasets through data sharing agreements between autism researchers and the NIH. To date, NDAR is considered the largest neuroscience and genomic data repository for autism research. In addition to biomedical data, NDAR contains a large collection of clinical and behavioral assessments and health outcomes from novel interventions. Importantly, NDAR has a global unique patient identifier that can be linked to aggregated individual-level data for hypothesis generation and testing, and for replicating research findings. As such, NDAR promotes collaboration and maximizes public investment in the original data collection. As screening and diagnostic technologies as well as interventions for children with autism are expensive, health services research (HSR) and health technology assessment (HTA) are needed to generate more evidence to facilitate implementation when warranted. This article describes NDAR and explains its value to health services researchers and decision scientists interested in autism and other mental health conditions. We provide a description of the scope and structure of NDAR and illustrate how data are likely to grow over time and become available for HSR and HTA.

Indexed as

Autistic DisorderDatabases, FactualChildCooperative BehaviorData CollectionHealth Services ResearchHumansInformation DisseminationMass ScreeningTechnology Assessment, BiomedicalUnited States

Identifiers

PMID26446859
PMCPMC4761298
OpenAlexW2174595477

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.